Michael Sabolek

596 total citations
20 papers, 442 citations indexed

About

Michael Sabolek is a scholar working on Neurology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Michael Sabolek has authored 20 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Neurology, 6 papers in Molecular Biology and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Michael Sabolek's work include Parkinson's Disease Mechanisms and Treatments (5 papers), Neurogenesis and neuroplasticity mechanisms (5 papers) and Pharmacological Effects and Toxicity Studies (4 papers). Michael Sabolek is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (5 papers), Neurogenesis and neuroplasticity mechanisms (5 papers) and Pharmacological Effects and Toxicity Studies (4 papers). Michael Sabolek collaborates with scholars based in Germany, United States and Austria. Michael Sabolek's co-authors include Alexander Storch, Jan Kassubek, Alexander Unrath, R. Bachus, Uwe Runge, Johannes Schwarz, Daniel Ecker, G. Arnold, Michael Kowalski and Alexander Dressel and has published in prestigious journals such as Stem Cells, Neuroreport and Cell and Tissue Research.

In The Last Decade

Michael Sabolek

18 papers receiving 434 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Sabolek Germany 12 145 122 104 83 62 20 442
Neşe Tuncer Türkiye 12 200 1.4× 75 0.6× 103 1.0× 25 0.3× 39 0.6× 25 572
Sevinç Aktan Türkiye 10 151 1.0× 75 0.6× 80 0.8× 25 0.3× 29 0.5× 17 450
V. Muoio Brazil 8 103 0.7× 94 0.8× 128 1.2× 28 0.3× 13 0.2× 9 566
Toshihiro Yorozuya Japan 14 65 0.4× 67 0.5× 118 1.1× 40 0.5× 46 0.7× 61 587
Hee‐Kwon Park South Korea 10 58 0.4× 71 0.6× 137 1.3× 27 0.3× 62 1.0× 11 387
T. White United States 9 56 0.4× 89 0.7× 96 0.9× 58 0.7× 25 0.4× 10 561
Shinsaku Nishio Japan 13 147 1.0× 110 0.9× 161 1.5× 93 1.1× 14 0.2× 20 476
Shingo Mitaki Japan 13 91 0.6× 48 0.4× 108 1.0× 39 0.5× 56 0.9× 45 461
Dan Lindholm Sweden 12 73 0.5× 257 2.1× 205 2.0× 80 1.0× 12 0.2× 15 494
Ivan Marinković Finland 10 157 1.1× 51 0.4× 115 1.1× 29 0.3× 13 0.2× 32 540

Countries citing papers authored by Michael Sabolek

Since Specialization
Citations

This map shows the geographic impact of Michael Sabolek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Sabolek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Sabolek more than expected).

Fields of papers citing papers by Michael Sabolek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Sabolek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Sabolek. The network helps show where Michael Sabolek may publish in the future.

Co-authorship network of co-authors of Michael Sabolek

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Sabolek. A scholar is included among the top collaborators of Michael Sabolek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Sabolek. Michael Sabolek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lang, Nicolas, Max Lange, Friedhelm C. Schmitt, et al.. (2016). Intravenous lacosamide in clinical practice–Results from an independent registry. Seizure. 39. 5–9. 21 indexed citations
2.
3.
4.
Ecker, D., E. Mauch, & Michael Sabolek. (2012). Multimodale Komplexbehandlung bei Multipler Sklerose. Der Nervenarzt. 84(2). 197–201.
5.
Winkler, Jürgen, Reinhard Ehret, Thomas Büttner, et al.. (2011). Parkinson’s disease risk score: moving to a premotor diagnosis. Journal of Neurology. 258(S2). 311–315. 38 indexed citations
6.
Dressel, Alexander, Michael Kowalski, Uwe Runge, et al.. (2010). Cerebrospinal fluid promotes survival and astroglial differentiation of adult human neural progenitor cells but inhibits proliferation and neuronal differentiation. BMC Neuroscience. 11(1). 48–48. 41 indexed citations
7.
Gdynia, Hans‐Jürgen, Anne‐Dorte Sperfeld, Alexander Unrath, et al.. (2009). Histopathological analysis of skeletal muscle in patients with Parkinson's disease and ‘dropped head’/‘bent spine’ syndrome. Parkinsonism & Related Disorders. 15(9). 633–639. 51 indexed citations
8.
Ecker, Daniel, Alexander Unrath, Jan Kassubek, & Michael Sabolek. (2009). Dopamine Agonists and their risk to induce psychotic episodes in Parkinson's disease: a case-control study. BMC Neurology. 9(1). 23–23. 57 indexed citations
9.
Sabolek, Michael, et al.. (2009). Stimulation dependent induction of fear and depression in deep brain stimulation: a case report. Journal of Medical Case Reports. 3(1). 9136–9136. 1 indexed citations
10.
Dressel, Alexander, et al.. (2009). Adult cerebrospinal fluid inhibits neurogenesis but facilitates gliogenesis from fetal rat neural stem cells. Journal of Neuroscience Research. 87(14). 3054–3066. 25 indexed citations
11.
Sabolek, Michael, Bernd Baumann, Maria Heinrich, et al.. (2009). Initiation of Dopaminergic Differentiation of Nurr1− Mesencephalic Precursor Cells Depends on Activation of Multiple Mitogen-Activated Protein Kinase Pathways. Stem Cells. 27(8). 2009–2021. 14 indexed citations
12.
Runge, Uwe, et al.. (2008). Thrombocytopenia during levetiracetam therapy. Epilepsy Research. 80(1). 91–92. 21 indexed citations
13.
Sabolek, Michael, et al.. (2008). Stage-dependent vulnerability of fetal mesencephalic neuroprogenitors towards dopaminergic neurotoxins. NeuroToxicology. 29(4). 714–721. 4 indexed citations
14.
Sabolek, Michael, Alexander Unrath, Anne‐Dorte Sperfeld, Bernhard J. Connemann, & Jan Kassubek. (2007). Psychotische Störung unter Rofecoxib. Psychiatrische Praxis. 34(4). 200–202. 3 indexed citations
15.
Sabolek, Michael, et al.. (2006). Dexamethasone blocks astroglial differentiation from neural precursor cells. Neuroreport. 17(16). 1719–1723. 26 indexed citations
16.
Sabolek, Michael, et al.. (2005). Multiple cerebral aneurysms as delayed complication of left cardiac myxoma: a case report and review. Acta Neurologica Scandinavica. 111(6). 345–350. 68 indexed citations
17.
Sabolek, Michael, et al.. (2005). Rabbit-Syndrom unter Olanzapineinnahme. Psychiatrische Praxis. 32(4). 202–204. 4 indexed citations
18.
Storch, Alexander, Michael Sabolek, Javorina Milošević, Sigrid C. Schwarz, & Johannes Schwarz. (2004). Midbrain-derived neural stem cells: from basic science to therapeutic approaches. Cell and Tissue Research. 318(1). 15–22. 31 indexed citations
19.
Sabolek, Michael, et al.. (2004). Thrombozytopenie unter Trientene zur Behandlung des Morbus Wilson mit neurologischen Symptomen. Aktuelle Neurologie. 31(5). 246–249. 1 indexed citations
20.
Küppers, Eva, et al.. (2000). Developmental regulation of glutamic acid decarboxylase mRNA expression and splicing in the rat striatum by dopamine. Molecular Brain Research. 81(1-2). 19–28. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Neşe Tuncer Breakdown of academic impact, for papers by Sevinç Aktan Breakdown of academic impact, for papers by V. Muoio Breakdown of academic impact, for papers by Toshihiro Yorozuya Breakdown of academic impact, for papers by Hee‐Kwon Park Breakdown of academic impact, for papers by T. White Breakdown of academic impact, for papers by Shinsaku Nishio Breakdown of academic impact, for papers by Shingo Mitaki Breakdown of academic impact, for papers by Dan Lindholm Breakdown of academic impact, for papers by Ivan Marinković
Rankless by CCL
2026